Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

被引:19
|
作者
Stavropoulos, Konstantinos [1 ]
Imprialos, Konstantinos [1 ]
Pittaras, Andreas [2 ,3 ]
Faselis, Charles [2 ,3 ]
Narayan, Puneet [2 ,3 ]
Kokkinos, Peter [2 ,3 ]
机构
[1] Aristotle Univ Thessaloniki, Propaedeut Dept Med 2, Thessaloniki, Greece
[2] VAMC, Washington, DC USA
[3] Georgetown Univ, Sch Med, Washington, DC 20057 USA
关键词
Non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; lifestyle modification; weight loss; physical activity; nutrition; diet; CORONARY-HEART-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; BODY-MASS INDEX; PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; EXERCISE CAPACITY; WEIGHT-LOSS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; RISK-FACTORS;
D O I
10.2174/1570161115666170621080835
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is one of the most common diseases worldwide, affecting more than 30% of general population. High-fat diets, physical inactivity and obesity, all prevalent in the western societies, are strongly associated with the development and progression of NAFLD. Current drug therapies have not consistently shown substantial beneficial effects. Thus, lifestyle modification appears to be the optimal intervention in combating the disease. Accordingly, several studies have concluded that weight loss, via increase in physical activity, and dietary interventions could potential ameliorate biochemical, histological, and structural abnormalities of non-alcoholic fatty liver disease. The aim of this review is to summarize the findings of these lifestyle intervention studies and discuss the implementation of each intervention, and its effectiveness in the management of the disease in everyday clinical practice.
引用
收藏
页码:239 / 245
页数:7
相关论文
共 50 条
  • [41] Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Hattori, Sachiko
    Nomoto, Kazuomi
    Suzuki, Tomohiko
    Hayashi, Seishu
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [42] Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?
    Lanthier, Nicolas
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (19) : 2184 - 2188
  • [43] UNDERSTANDING RISK FOR NON-ALCOHOLIC STEATOHEPATITIS AND NON-ALCOHOLIC FATTY LIVER DISEASE IN MEDICARE AND MEDICAID CLAIMS
    Nelson, Katherine
    Gellar, Jonathan
    Anderson, Ryan Taylor
    Campbell, Patrick
    Chen, Arnold
    HEPATOLOGY, 2023, 78 : S2146 - S2147
  • [44] Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
    Jeong Woo Kim
    Young-Sun Lee
    Yang Shin Park
    Baek-Hui Kim
    Soo Yeon Lee
    Jong Eun Yeon
    Chang Hee Lee
    Scientific Reports, 10
  • [45] Navigating the Link Between Non-alcoholic Fatty Liver Disease/ Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome
    Gato, Sheila
    Garcia-Fernandez, Vanessa
    Gil-Gomez, Antonio
    Rojas, Angela
    Montero-Vallejo, Rocko
    Munoz-Hernandez, Rocko
    Romero-Gomez, Manuel
    EUROPEAN CARDIOLOGY REVIEW, 2024, 19
  • [46] Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic Steatohepatitis (NASH): Pathophysiology and Nutritional Aspects
    Schattenberg, Joern M.
    ERNAHRUNGS UMSCHAU, 2015, 62 (02): : M92 - M100
  • [47] Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Senavirathna, Tharani
    Shafaei, Armaghan
    Lareu, Ricky
    Balmer, Lois
    ANTIOXIDANTS, 2024, 13 (04)
  • [48] A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
    Ganguli, Surosree
    DeLeeuw, Peter
    Satapathy, Sanjaya K.
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2019, 11
  • [49] Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
    Daher, Saleh
    Cohen, Namma Lev
    Massarwa, Muhammad
    Mahamid, Mahmud
    Nasser, Mira
    Hazou, Wadi
    Oren, Rani
    Safadi, Rifaat
    Khoury, Tawfik
    PLOS ONE, 2018, 13 (11):
  • [50] Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A focused literature review
    Eguchi, Yuichiro
    Wong, Gabriel
    Lee, Emma
    Akhtar, Omar
    Lopes, Ricardo
    Sumida, Yoshio
    JGH OPEN, 2020, 4 (05): : 808 - 817